National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Español
Información en español
Quit Smoking Today
NCI Highlights
Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

The Nation's Investment in Cancer Research FY 2009

Past Highlights
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

recombinant human methionyl stem cell factor (ree-KOM-bih-nunt HYOO-mun meh-THY-oh-nil stem sel FAK-ter)

 A substance that causes blood stem cells (cells from which other types of cells develop) to change into different types of blood cells and increases the number and actions of these cells in the blood. It is being studied in the treatment of myelodysplasia. Recombinant human methionyl stem cell factor is a type of recombinant stem cell growth factor. Also called ancestim, r-metHuSCF, and Stemgen.



Previous Definitions:recombinant adenovirus-p53, recombinant fowlpox-CEA-MUC-1-TRICOM vaccine, recombinant fowlpox-TRICOM vaccine, recombinant human interleukin-2, recombinant human interleukin-11
Next Definitions:recombinant tissue plasminogen activator, recombinant vaccinia-CEA-MUC-1-TRICOM vaccine, recombinant vaccinia-TRICOM vaccine, reconstructive surgeon, reconstructive surgery

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov